News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
502,610 Results
Type
Article (25464)
Company Profile (184)
Press Release (476962)
Section
Business (157037)
Career Advice (1532)
Deals (26824)
Drug Delivery (36)
Drug Development (49409)
Employer Resources (97)
FDA (11562)
Job Trends (10667)
News (248037)
Policy (19187)
Tag
Academia (1891)
Alliances (41512)
Alzheimer's disease (735)
Approvals (11511)
Artificial intelligence (120)
Bankruptcy (193)
Best Places to Work (8652)
Biotechnology (143)
Breast cancer (59)
Cancer (576)
Career advice (1274)
Cell therapy (161)
Clinical research (38366)
Collaboration (286)
Compensation (96)
COVID-19 (1475)
C-suite (58)
Cystic fibrosis (73)
Data (603)
Diagnostics (5516)
Earnings (59981)
Employer resources (87)
Events (77227)
Executive appointments (197)
FDA (11858)
Funding (231)
Gene editing (56)
Gene therapy (124)
GLP-1 (269)
Government (1977)
Healthcare (13635)
Infectious disease (1518)
Inflammatory bowel disease (71)
Interviews (243)
IPO (12508)
Job creations (2278)
Job search strategy (1081)
Layoffs (212)
Legal (4348)
Lung cancer (92)
Manufacturing (97)
Medical device (12143)
Medtech (12148)
Mergers & acquisitions (14376)
Metabolic disorders (156)
Neuroscience (870)
NextGen Class of 2024 (4757)
Non-profit (2495)
Northern California (907)
Obesity (85)
Opinion (120)
Patents (73)
People (44687)
Phase I (12867)
Phase II (17074)
Phase III (12258)
Pipeline (164)
Postmarket research (1221)
Preclinical (5693)
Press Release (72)
Radiopharmaceuticals (193)
Rare diseases (153)
Real estate (4362)
Regulatory (13489)
Research institute (1838)
Resumes & cover letters (316)
Southern California (789)
Startups (3015)
United States (8431)
Vaccines (291)
Date
Last 7 days (570)
Last 30 days (1961)
Last 365 days (26921)
2024 (22693)
2023 (30932)
2022 (41227)
2021 (43950)
2020 (41601)
2019 (34854)
2018 (26290)
2017 (25329)
2016 (24088)
2015 (28742)
2014 (21804)
2013 (18218)
2012 (19419)
2011 (20029)
2010 (18687)
Location
Africa (523)
Arizona (117)
Asia (29577)
Australia (5088)
California (1982)
Canada (881)
China (127)
Colorado (92)
Connecticut (94)
Europe (64952)
Florida (281)
Georgia (76)
Illinois (203)
Indiana (139)
Kansas (81)
Maryland (346)
Massachusetts (1603)
Michigan (137)
Minnesota (208)
New Jersey (578)
New York (590)
North Carolina (510)
Northern California (907)
Ohio (90)
Pennsylvania (473)
South America (758)
Southern California (789)
Texas (271)
Utah (62)
Washington State (238)
502,610 Results for "applied genetic technologies corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Genetic Technologies Limited is pleased to invite investors to a webinar on June 27, 2024, at 4:15 p.m. ET.
June 21, 2024
·
3 min read
BioMidwest
Applied Genetic Technologies Corporation Urges Shareholders to Tender Their Shares by November 28, 2022
Applied Genetic Technologies Corporation, President and Chief Executive Officer, Sue Washer, sent the following letter to stockholders.
November 14, 2022
·
5 min read
BioMidwest
Applied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022
Applied Genetic Technologies Corporation, President and Chief Executive Officer, Sue Washer, sent the following letter to shareholders:
November 3, 2022
·
6 min read
Pharm Country
Applied DNA Announces Pricing of $12 Million Public Offering
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced the pricing of a public offering with gross proceeds to the Company expected to be approximately $12.0 million, before deducting placement agent fees and other estimated expenses payable by the Company.
May 28, 2024
·
5 min read
Pharm Country
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health (“NYSDOH”) approved the Company’s TR8™ PGx (“TR8") pharmacogenomic (PGx) testing service.
June 13, 2024
·
5 min read
BioMidwest
Cincinnati Children’s to expand clinical trials with launch of Applied Gene and Cell Therapy Center
Cincinnati Children’s has begun work on an Applied Gene and Cell Therapy Center, which will enable the health system to increase clinical trials of innovative drugs and biological therapeutics for patients with cancer, blood diseases or genetic disorders.
May 29, 2024
·
5 min read
Biotech Beach
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
The Bruker Applied Mass Spectrometry Division is showcasing some of its latest innovations at ASMS 2024.
June 3, 2024
·
4 min read
Genetic Technologies Announces $2 Million Registered Direct Offering
Genetic Technologies Limited announced that it has entered into a definitive agreement for the purchase and sale in a registered direct offering of 1,000,000 American Depositary Shares, each representing thirty ordinary shares of the Company, at a purchase price of $2.00 per ADS.
April 18, 2024
·
5 min read
Deals
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
May 10, 2024
·
3 min read
Business
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced consolidated financial results for its second fiscal quarter ended March 31, 2024.
May 10, 2024
·
11 min read
1 of 50,261
Next